In gliomas, NG2/CSPG4 is one of the highly upregulated proteoglycans [96] that increases the invasive and migratory capabilities of glioma cells by facilitating interactions with ECM proteins, such as collagens II, V, VI, and laminin [97]. The gene discussed is CSPG4; the disease is glioma.